Withdrawal of inhaled corticosteroids in people with COPD in primary care: a randomised controlled trial.
about
Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary diseaseA re-evaluation of the role of inhaled corticosteroids in the management of patients with chronic obstructive pulmonary diseaseAppropriate use of inhaled corticosteroids in COPD: the candidates for safe withdrawalWithdrawal of inhaled corticosteroids can be safe in COPD patients at low risk of exacerbation: a real-life study on the appropriateness of treatment in moderate COPD patients (OPTIMO)Inhaled corticosteroids in chronic obstructive pulmonary disease: a pro-con perspective.The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis.Withdrawal of inhaled corticosteroids in individuals with COPD--a systematic review and comment on trial methodology.Mortality and drug therapy in patients with chronic obstructive pulmonary disease: a network meta-analysis.Factors associated with the prescription of inhaled corticosteroids in GOLD group A and B patients with COPD - subgroup analysis of the Taiwan obstructive lung disease cohort.Does roflumilast decrease exacerbations in severe COPD patients not controlled by inhaled combination therapy? The REACT study protocolApplying the wisdom of stepping down inhaled corticosteroids in patients with COPD: a proposed algorithm for clinical practiceThe role of pharmacotherapy in mild to moderate chronic obstructive pulmonary disease.Pharmacological treatment of COPD.Risk-to-benefit ratio of inhaled corticosteroids in patients with COPD.Pharmacological basis and scientific rationale underlying the targeted use of inhaled corticosteroid/long-acting β2-adrenergic agonist combinations in chronic obstructive pulmonary disease treatment.Recent advances in the management of chronic obstructive pulmonary disease.Use of inhaled corticosteroids in COPD: improving efficacy.The place of inhaled corticosteroids in the treatment of chronic obstructive pulmonary disease: a narrative review.Chronic obstructive pulmonary disease lost in translation: Why are the inhaled corticosteroids skeptics refusing to go?Abrupt withdrawal of inhaled corticosteroids does not result in spirometric deterioration in chronic obstructive pulmonary disease: Effect of phenotyping?Discontinuing inhaled steroids might not be safe in severe COPD cases.A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease.Inhaled therapies in patients with moderate COPD in clinical practice: current thinking.Response to Indacaterol/Glycopyrronium (IND/GLY) by Sex in Patients with COPD: A Pooled Analysis from the IGNITE Program.Should Patients Switched from D to B in the GOLD 2017 Classification be Discontinued from Inhaled Corticosteroids?Escalation and De-escalation of Therapy in COPD: Myths, Realities and Perspectives.The impact of 2011 and 2017 Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) guidelines on allocation and pharmacological management of patients with COPD in Taiwan: Taiwan Obstructive Lung Disease (TOLD) study
P2860
Q24197989-B075B43D-26D6-493F-A7B9-EB0F630FA5DEQ26801661-F02231CB-5EFD-4D2B-B897-9B0996244AC9Q28074169-BFB18B87-86A8-4CD8-874B-B9FEBF78B63DQ34003435-ACA1FCC8-4C3E-4564-9CAC-8E8E087E1A8AQ34065276-97AE47E6-6669-4EA8-AF93-B639C96B0E06Q34522113-960AFDA9-79A7-4D30-9E79-154F37D8AF9BQ35257612-5D441100-08AA-4DE4-A078-66F779F06239Q35838660-DD789384-5002-46BC-B1CA-9E4B31AA0CE0Q36072536-A6F4A70F-2B2A-41DB-BA09-ED67BBEC2A50Q36086153-BC942E5D-1681-40E5-B55B-CCE3E67074E9Q36332206-D86F4344-61D6-4ABE-A10C-28CBFBFFADDDQ37847761-3525A762-0940-41DA-A3AC-BDB0BE36E38DQ37924598-C7FFC5B2-4BE9-4302-964F-350775C768D2Q38058413-6449862B-D5E0-47F9-AFAD-B8B9C5198C75Q38550921-91FE4C2B-18BC-4462-BD4C-FD5A83CCD32EQ38701325-BCA4B360-8BAD-4E9E-91D6-E727F615CFEBQ38726082-6BE59FEC-8BEA-4E03-BFBC-A0C3F4926DDCQ38827675-2BA338EA-9ECA-42CB-8D3C-980AB9D9F130Q39461476-E05DF819-36A5-472E-AC00-8D654D731150Q42007380-8CCF7721-1B7C-4398-BF2B-C7AAE5EA27F9Q46682329-759B625C-B96B-4D5C-ACB5-603013ACEFF3Q47138049-7BA356BD-2B50-478A-BCB8-5984411278D5Q47661714-98C46C39-2DD4-4F6A-8C08-466931815145Q47737129-01734B1B-1263-4AD2-9E63-F7C91CB0E82AQ48343193-403747A7-DBDC-40A6-98D6-03E6F554F83FQ51599981-277B0CFF-5EB1-46C1-B318-43F65F4BFB6AQ57492222-947D01F0-C913-42A9-B1DD-3AEB22C42A3A
P2860
Withdrawal of inhaled corticosteroids in people with COPD in primary care: a randomised controlled trial.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Withdrawal of inhaled corticos ...... a randomised controlled trial.
@ast
Withdrawal of inhaled corticos ...... a randomised controlled trial.
@en
type
label
Withdrawal of inhaled corticos ...... a randomised controlled trial.
@ast
Withdrawal of inhaled corticos ...... a randomised controlled trial.
@en
prefLabel
Withdrawal of inhaled corticos ...... a randomised controlled trial.
@ast
Withdrawal of inhaled corticos ...... a randomised controlled trial.
@en
P2093
P2860
P356
P1433
P1476
Withdrawal of inhaled corticos ...... a randomised controlled trial.
@en
P2093
Aklak B Choudhury
Carolyn M Dawson
Chris J Griffiths
Gene S Feder
Hazel E Kilvington
Jadwiga A Wedzicha
Sandra Eldridge
Wai-Yee James
P2860
P2888
P356
10.1186/1465-9921-8-93
P577
2007-12-27T00:00:00Z
P5875
P6179
1051267892